Handelsbanken Fonder AB GPCR — STRUCTURE THERAPEUTICS INC SPONSORED ADS

Ownership history in Handelsbanken Fonder AB  ·  5 quarters on record

AI Ownership Summary

Handelsbanken Fonder AB reported STRUCTURE THERAPEUTICS INC SPONSORED ADS (GPCR) in 5 quarterly 13F filings from 2024 Q4 through 2026 Q2. Peak portfolio weight reached 0.03% in 2025 Q2. The latest visible filing shows GPCR at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this GPCR ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Handelsbanken Fonder AB's position in STRUCTURE THERAPEUTICS INC SPONSORED ADS, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

GPCR was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.03% in 2025 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

GPCR stock page Handelsbanken Fonder AB fund profile Handelsbanken Fonder AB full holdings
How Handelsbanken Fonder AB held GPCR — position size vs. price
% of Fund (quarterly)    GPCR price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 5 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 REDUCED 88.5% -34.7% ✅ 19,400 -148,600 -88.5% 0.00% $1K 2026-07-10 $53.36
2025 Q3 REDUCED 55.8% +140.6% ❌ 168,000 -212,000 -55.8% 0.01% $4.7M 2025-11-12 $35.92
2025 Q2 UNCHANGED — — — 380,000 — 0% 0.03% $7.9M 2025-08-12 $18.74
2025 Q1 ADDED — — — 380,000 +215,000 +130.3% 0.03% $6.6M 2025-04-15 $18.90
2024 Q4 INITIATED — — — 165,000 — — 0.02% $4.5M 2025-02-03 $28.35

🏢 Other funds also holding GPCR

As of 2026 Q2 — sorted by position size

NEXTBio Capital Management LP 7.71% BVF INC/IL 3Y 7Y 4.62% Davern Capital Partners, LP 4.08% Deep Track Capital, LP 3Y 3.7% B Group, Inc. 3.53% Avoro Capital Advisors LLC 3Y 7Y 3.16% Casdin Capital, LLC 3Y 7Y 3.16% Catalio Capital Management, LP 2.79% Parkman Healthcare Partners LLC 3Y 2.67% ORBIMED ADVISORS LLC 3Y 7Y 2.2%

FAQ About Handelsbanken Fonder AB and GPCR

These are the practical questions this page is built to answer before you even open the full history table.

How long has Handelsbanken Fonder AB reported owning GPCR?

Handelsbanken Fonder AB reported GPCR across 5 quarterly 13F filings, from 2024 Q4 through 2026 Q2.

What was the largest reported GPCR position in Handelsbanken Fonder AB's portfolio?

The largest reported portfolio weight for GPCR was 0.03% in 2025 Q2.

What is the latest reported GPCR position on this page?

The most recent filing on this page is 2026 Q2, when Handelsbanken Fonder AB reported 19,400 shares, equal to 0.00% of portfolio, with an estimated market value of $1K.

What does the chart on this GPCR ownership page compare?

The chart compares Handelsbanken Fonder AB's quarterly GPCR portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Handelsbanken Fonder AB time their GPCR position?

Based on 13F filing dates vs. subsequent GPCR price moves, Handelsbanken Fonder AB correctly timed 0 out of 3 reported position changes (0%). The annualised alpha on GPCR relative to SPY over the holding period was +13.0%.

← Back to Handelsbanken Fonder AB Holdings